S Badve

897 total citations
21 papers, 620 citations indexed

About

S Badve is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, S Badve has authored 21 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in S Badve's work include Breast Lesions and Carcinomas (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). S Badve is often cited by papers focused on Breast Lesions and Carcinomas (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). S Badve collaborates with scholars based in United States, United Kingdom and Poland. S Badve's co-authors include J P Sloane, Robert P. Gray, Carl Yoshizawa, David L. Page, Nancy E. Davidson, Steven M. Butler, Joseph A. Sparano, J. N. Ingle, Lawrence J. Solin and G. W. Sledge and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

S Badve

20 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Badve United States 7 348 338 185 176 85 21 620
Gennaro Limite Italy 11 320 0.9× 392 1.2× 146 0.8× 119 0.7× 67 0.8× 32 674
Bernard Chevallier France 10 295 0.8× 340 1.0× 131 0.7× 158 0.9× 55 0.6× 14 574
C. Bryce Canada 8 407 1.2× 413 1.2× 142 0.8× 164 0.9× 107 1.3× 15 707
Saudade André Portugal 17 361 1.0× 355 1.1× 195 1.1× 230 1.3× 140 1.6× 51 812
Eloise Scarano Italy 11 408 1.2× 489 1.4× 209 1.1× 115 0.7× 53 0.6× 17 690
J-Y Pierga France 10 290 0.8× 215 0.6× 103 0.6× 116 0.7× 75 0.9× 17 450
AD Thor United States 2 517 1.5× 456 1.3× 203 1.1× 278 1.6× 99 1.2× 2 819
Cynthia Aparecida Bueno de Toledo Osório Brazil 18 311 0.9× 260 0.8× 204 1.1× 146 0.8× 93 1.1× 49 786
Chikako Shimizu Japan 17 484 1.4× 626 1.9× 157 0.8× 205 1.2× 90 1.1× 53 975
Helen Trihia Greece 10 262 0.8× 273 0.8× 113 0.6× 149 0.8× 33 0.4× 24 465

Countries citing papers authored by S Badve

Since Specialization
Citations

This map shows the geographic impact of S Badve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Badve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Badve more than expected).

Fields of papers citing papers by S Badve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Badve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Badve. The network helps show where S Badve may publish in the future.

Co-authorship network of co-authors of S Badve

This figure shows the co-authorship network connecting the top 25 collaborators of S Badve. A scholar is included among the top collaborators of S Badve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Badve. S Badve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Solin, Lawrence J., Robert P. Gray, Frederick L. Baehner, et al.. (2013). A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast. JNCI Journal of the National Cancer Institute. 105(10). 701–710. 335 indexed citations
3.
Adams, Sylvia, Sandra Demaria, LJ Goldstein, et al.. (2013). Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. Cancer Research. 73(24_Supplement). S1–7. 13 indexed citations
4.
Nakshatri, Harikrishna & S Badve. (2011). FOXA1 (forkhead box A1). Atlas of Genetics and Cytogenetics in Oncology and Haematology.
5.
6.
Gray, Robert P., LJ Goldstein, BH Childs, et al.. (2009). GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.. Cancer Research. 69(2_Supplement). 25–25. 3 indexed citations
7.
Duchnowska, Renata, Jacek Jassem, Mangesh A. Thorat, et al.. (2009). Molecular characteristics of matched brain metastasis (BM) versus the primary breast cancer (PBC).. Cancer Research. 69(2_Supplement). 2028–2028. 1 indexed citations
8.
Gökmen‐Polar, Yesim, et al.. (2009). Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.. Cancer Research. 69(2_Supplement). 3020–3020. 2 indexed citations
9.
Gray, Robert P., Barrett H. Childs, Tara Maddala, et al.. (2008). HER2 concordance between central laboratory immunohistochemistry and quantitative reverse transcription polymerase chain reaction in Intergroup Trial E2197. Journal of Clinical Oncology. 26(15_suppl). 22009–22009. 4 indexed citations
10.
Thorat, Mangesh A., Caterina Marchiò, Akira Morimiya, et al.. (2007). Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. Journal of Clinical Pathology. 61(3). 327–332. 97 indexed citations
11.
Mohsin, S K, et al.. (2005). Assessment of variability in diagnosing "Atypia" in columnar cell lesions (CCL) of the breast. Laboratory Investigation. 18. 3 indexed citations
12.
Goulet, Robert J., et al.. (2004). Pilot trial assessing the feasibility of intra-ductal delivery of epirubicin (epi)-containing nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM). Journal of Clinical Oncology. 22(14_suppl). 828–828. 4 indexed citations
13.
Brown, Justin, Jamie Von Roenn, Ruth O’Regan, et al.. (2004). A phase II study of the proteasome inhibitor PS-341 in patients (pts) with metastatic breast cancer (MBC). Journal of Clinical Oncology. 22(14_suppl). 546–546. 11 indexed citations
14.
Tonetti, Debra A., et al.. (2003). Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. British Journal of Cancer. 88(9). 1400–1402. 53 indexed citations
15.
Badve, S, et al.. (2001). Mammary intraductal proliferations A morphologic and immunohistochemical characterization. Laboratory Investigation. 81(1). 36. 3 indexed citations
16.
O’Regan, Ruth, et al.. (2001). Characteristics of raloxifene-stimulated breast tumors in vivo. 69(3). 1 indexed citations
17.
Badve, S, et al.. (2001). PHYLLODES TUMORS OF BREAST. 2. 39–47. 3 indexed citations
18.
Badve, S & J P Sloane. (1995). Pseudoangiomatous hyperplasia of male breast. Histopathology. 26(5). 463–466. 46 indexed citations
19.
Andreyev, Jervoise, David Cunningham, V Nicolson, et al.. (1995). Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors.. Journal of Clinical Oncology. 13(6). 1486–1492. 34 indexed citations
20.
Andreyev, Jervoise, Anne Rigg, David Cunningham, et al.. (1995). 560 Infusional 5-fluorouracil with alpha interferon as a palliative treatment for patients with symptomatic malignant neuroendocrine tumours. European Journal of Cancer. 31. S119–S119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gennaro Limite Breakdown of academic impact, for papers by Bernard Chevallier Breakdown of academic impact, for papers by C. Bryce Breakdown of academic impact, for papers by Saudade André Breakdown of academic impact, for papers by Eloise Scarano Breakdown of academic impact, for papers by J-Y Pierga Breakdown of academic impact, for papers by AD Thor Breakdown of academic impact, for papers by Cynthia Aparecida Bueno de Toledo Osório Breakdown of academic impact, for papers by Chikako Shimizu Breakdown of academic impact, for papers by Helen Trihia
Rankless by CCL
2026